StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Johnson & Johnson
NYSE:JNJ
Sector
Location
Market Cap
USD 405.32 B
Share Price
USD 168.30
Avg Daily Volume
8,376,966
Change (1 day)
-0.74%
Change (1 year)
5.42%
Change (YTD)
16.37%
Johnson & Johnson Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 30, 2025: 29.95%
Johnson & Johnson Return on Equity (ROE) is 29.95% for the Trailing 12 Months (TTM) ending March 30, 2025, a -44.51% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
-
Johnson & Johnson Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 53.97%, a 216.66% change year over year.
-
Johnson & Johnson Return on Equity (ROE) for the Trailing 12 Months (TTM) ending April 02, 2023 was 17.04%, a -37.99% change year over year.
-
Johnson & Johnson Return on Equity (ROE) for the Trailing 12 Months (TTM) ending April 03, 2022 was 27.49%, a 16.64% change year over year.
-
Johnson & Johnson Return on Equity (ROE) for the Trailing 12 Months (TTM) ending April 04, 2021 was 23.57%, a -17.71% change year over year.
Competitors
GSK plc
USD 18.71
GSK.L
-0.07
-0.36%
Haleon plc
USD 4.91
HLN.L
-0.02
-0.37%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 28.43
600436.SS
-0.33
-1.15%
Yunnan Baiyao Group Co.,Ltd
USD 7.88
000538.SZ
-0.09
-1.09%
Nahdi Medical Company
USD 34.76
4164.SR
-0.24
-0.70%
Ajanta Pharma Limited
USD 32.17
AJANTPHARM.NS
-0.17
-0.52%
Jamjoom Pharmaceuticals Factory Company
USD 47.03
4015.SR
-0.09
-0.18%
Rohto Pharmaceutical Co.,Ltd.
USD 14.26
4527.T
-0.25
-1.71%
Gerresheimer AG
USD 58.14
GXI.DE
+1.33
2.34%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.64
600572.SS
-0.01
-0.84%
Eli Lilly and Company
USD 812.69
LLY
+7.26
0.90%
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
Key Data
| Date | Return on Equity (ROE) | Return on Assets (ROA) | Revenue Per Share | Free Cash Flow Per Share |
|---|
Competitors
GSK plc
USD 18.71
GSK.L
-0.07
-0.36%
Haleon plc
USD 4.91
HLN.L
-0.02
-0.37%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 28.43
600436.SS
-0.33
-1.15%
Yunnan Baiyao Group Co.,Ltd
USD 7.88
000538.SZ
-0.09
-1.09%
Nahdi Medical Company
USD 34.76
4164.SR
-0.24
-0.70%
Ajanta Pharma Limited
USD 32.17
AJANTPHARM.NS
-0.17
-0.52%
Jamjoom Pharmaceuticals Factory Company
USD 47.03
4015.SR
-0.09
-0.18%
Rohto Pharmaceutical Co.,Ltd.
USD 14.26
4527.T
-0.25
-1.71%
Gerresheimer AG
USD 58.14
GXI.DE
+1.33
2.34%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.64
600572.SS
-0.01
-0.84%
Eli Lilly and Company
USD 812.69
LLY
+7.26
0.90%
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%